Drug Trial Radar · NCT03924414
Trial of Parkinson's And Zoledronic Acid
Last checked: Nov 19, 2026Latest source record: Jun 25, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
2,721
Actual
Start
Nov 15, 2019
Primary completion
Feb 28, 2026
Study completion Feb 28, 2026
Sponsor
- Lead sponsor
- California Pacific Medical Center Research InstituteAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- National Institute on Aging (NIA); University of California, San Francisco; Duke University; University of Pittsburgh; Parkinson's Foundation
- First posted
- Apr 23, 2019
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 60 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This home-based study is a randomized (1:1) placebo-controlled trial of a single infusion of zoledronic acid-5 mg (ZA) for the prevention of fractures in men and women aged 60 years and older with Parkinson's disease and parkinsonism with at least 2 years of follow-up. A total of 2650 participants will be enrolled and randomized in the United States. Participants, follow-up outcome assessors, and study investigators will be blinded to assigned study treatment. This trial is funded by the National Institute of Aging.
Conditions
- Parkinson Disease
- Osteoporosis
- Parkinsonism
- Parkinson's Disease and Parkinsonism
- Atypical Parkinsonism
- Progressive Supranuclear Palsy
- Multiple System Atrophy
- Vascular Parkinsonism
- Dementia With Lewy Bodies
Interventions
Zoledronic Acid 5Mg/Bag 100Ml InjDrug
Zoledronic acid 5mg/100 ml IV infusion: Zoledronic acid-5 mg (ZA) is an FDA approved therapy for men and postmenopausal women for the treatment and prevention of osteoporosis.
PlaceboOther
Normal Saline 100 ml (placebo) IV infusion
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants with Clinical FracturesTime frame: 2 years
- Number of Participants with Clinical FracturesTime frame: 5 years
Locations
77 sites in 1 country. Site status is shown where the registry gives one.
Mayo Clinic
Scottsdale, Arizona
Washington Regional Medical Center
Fayetteville, Arkansas
University of Arkansas for Medical Sciences
Little Rock, Arkansas
Sutter Health
Berkeley, California
Parkinson's and Movement Disorder Institute
Fountain Valley, California
University of California, Irvine
Irvine, California
Loma Linda University
Loma Linda, California
Cedars-Sinai Medical Center
Los Angeles, California
University of California, Los Angeles
Los Angeles, California
Valley Parkinson Clinic
Los Gatos, California
Parkinson's Disease and Movement Disorder Center of Silicon Valley
Palo Alto, California
University of California, Riverside
Riverside, California
Sutter Health
Sacramento, California
University of California, Davis
Sacramento, California
University of California, San Francisco
San Francisco, California
University of Colorado, Denver
Aurora, Colorado
St. Mary's Medical Center
Grand Junction, Colorado
University of Connecticut
Farmington, Connecticut
University of Connecticut
Farmington, Connecticut
Hartford Healthcare
Hartford, Connecticut
University of Florida
Gainesville, Florida
Mayo Clinic
Jacksonville, Florida
Parkinson's Foundation
Miami, Florida
University of Miami
Miami, Florida
Morehouse School of Medicine
Atlanta, Georgia
Emory University School of Medicine
Atlanta, Georgia
Augusta University
Augusta, Georgia
Queens Medical Center
Honolulu, Hawaii
Northwestern Medicine
Chicago, Illinois
Cook County Health & Hospitals System
Chicago, Illinois
Rush University
Chicago, Illinois
University of Chicago
Chicago, Illinois
Loyola University
Chicago, Illinois
Edward Hines, Jr. VA Hospital
Hines, Illinois
University of Kansas Medical Center
Kansas City, Kansas
University of Kentucky
Lexington, Kentucky
Ochsner Health System
New Orleans, Louisiana
Massachusetts General Hospital
Boston, Massachusetts
Beth Israel Deaconess Medical Center
Boston, Massachusetts
Boston University
Boston, Massachusetts
Showing 40 of 77 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.